Boris Fehse
Impact in
- Hematology top 0.2%
- Hematopoietic Stem Cell Transplantation
- Multiple Myeloma Research and Treatments
- Acute Myeloid Leukemia Research
- Genetics top 0.5%
- Virus-based gene therapy research
Papers in
-
- CRISPR and Genetic Engineering 58
- RNA Interference and Gene Delivery 34
- Genetics 81
- Virus-based gene therapy research 78
- Myeloproliferative Neoplasms: Diagnosis and Treatment 26
- Co-authors
- Nicolaus Kröger (64 shared papers)Axel R. Zander (43 shared papers)Christopher Baum (14 shared papers)Zhixiong Li (14 shared papers)Olga Kustikova (15 shared papers)Kristoffer Riecken (60 shared papers)Kristoffer Weber (13 shared papers)Carol Stocking (18 shared papers)
- Journals
- Blood (28 papers)Bone Marrow Transplantation (17 papers)Gene Therapy (15 papers)Human Gene Therapy (12 papers)Experimental Hematology (10 papers)
- Partner nations
- GermanyUnited StatesUnited Kingdom
In The Last Decade
Boris Fehse
241 papers receiving 9.2k citations
Boris Fehse's Hit Papers
Peers
Comparison fields: 5 of 147
- Hematology 1.9k
- Genetics 1.0k
- Oncology 2.5k
- Genetics 2.7k
- Molecular Biology 4.8k
Countries citing papers authored by Boris Fehse
This map shows the geographic impact of Boris Fehse's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Boris Fehse with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Boris Fehse more than expected).
Fields of papers citing papers by Boris Fehse
This network shows the impact of papers produced by Boris Fehse. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Boris Fehse. The network helps show where Boris Fehse may publish in the future.
Co-authors
The 25 scholars most cited alongside Boris Fehse, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 256 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Murine Leukemia Induced by Retroviral Gene Marking Hit paper breakdown → | 2002 | 514 |
| 2 | 2003 | 320 | |
| 3 | 2006 | 293 | |
| 4 | 2005 | 274 | |
| 5 | 2008 | 267 | |
| 6 | 2002 | 190 | |
| 7 | 2004 | 179 | |
| 8 | 2002 | 152 | |
| 9 | 2008 | 151 | |
| 10 | 2011 | 149 | |
| 11 | 2003 | 139 | |
| 12 | 2014 | 127 | |
| 13 | 2014 | 120 | |
| 14 | 2011 | 114 | |
| 15 | CD19-targeted chimeric antigen receptor T cell therapy in two patients with multiple sclerosis Hit paper breakdown → | 2024 | 106 |
| 16 | 2006 | 106 | |
| 17 | 2017 | 100 | |
| 18 | 2015 | 99 | |
| 19 | 2003 | 99 | |
| 20 | 2004 | 98 |
About Boris Fehse
Boris Fehse is a scholar working on Molecular Biology, Genetics, Oncology, Hematology and Genetics, having authored 256 papers that have together received 9.3k indexed citations. Recurring topics across this work include Virus-based gene therapy research (78 papers), CRISPR and Genetic Engineering (58 papers), CAR-T cell therapy research (45 papers), RNA Interference and Gene Delivery (34 papers), Hematopoietic Stem Cell Transplantation (33 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (26 papers), Chronic Myeloid Leukemia Treatments (19 papers) and Acute Myeloid Leukemia Research (15 papers). The work is most often cited by research in Hematology (1.9k citations), Genetics (1.0k citations), Oncology (2.5k citations), Genetics (2.7k citations) and Molecular Biology (4.8k citations). Boris Fehse has collaborated with scholars based in Germany, United States and United Kingdom. Frequent co-authors include Nicolaus Kröger, Axel R. Zander, Christopher Baum, Zhixiong Li, Olga Kustikova, Kristoffer Riecken, Kristoffer Weber, Carol Stocking, Francis Ayuk and Tatjana Zabelina. Their work appears in journals such as Blood, Bone Marrow Transplantation, Gene Therapy, Human Gene Therapy and Experimental Hematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.